AzTrials
AzTrials

Intubation;DifficultNCT04174833

GlideScope Videolaryngoscopy in Patients With Reduced Mouth Opening

An observational study of Intubation;Difficult and Videolaryngoscopy, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the clinical performance, quality of larynx visualization and difficulty of videolaryngoscopic intubation in patients with a reduced mouth opening (1.0 to 3.0 cm) utilizing the latest generation of GlideScopeTM Spectrum low profile laryngoscopy system. Read more about this study

Who is it for?
Ages 18 years and older
How many people
30 participants
Where
1 siteGermany
Study dates
20 Jan 2021to 17 Nov 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients scheduled for non-cardiac surgery under general anesthesia with a need for endotracheal intubation presenting at the Anesthesiology Preassessment Clinic of the Hamburg University Hospital with a mouth opening between 1.0 and 3.0 cm within the recruiting period.

Who may be able to join

  • Patients scheduled for non-cardiac surgery
  • Required general anesthesia and endotracheal intubation
  • Mouth opening between 1.0 and 3.0 cm (any reason) recognized during preoperative assessment
  • Written consent provided

Who cannot join

  • Pregnant or breastfeeding women
  • Confirmed indication for awake fiberoptic intubation, especially due to enoral and pharyngeal tumors, abscesses or other obstructive lesions
  • Endotracheal intubation planned without deep general anesthesia or without neuromuscular blockade (e.g. awake videolaryngoscopy)
  • Qualification for rapid sequence anesthesia induction due to risk of pulmonary aspiration
  • Loose teeth

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Medical Center Hamburg-Eppendorf

    Hamburg, 20246

Other trials in Germany

About this study

Official title: GlideScope Videolaryngoscopy in Patients With Reduced Mouth Opening, a Prospective Cohort Study

This study aims to evaluate the clinical performance, quality of larynx visualization and difficulty of videolaryngoscopic intubation in patients with a reduced mouth opening (1.0 to 3.0 cm) utilizing the latest generation of GlideScopeTM Spectrum low profile laryngoscopy system.

Read the detailed description

Reduced mouth opening in adults has been proven an important risk factor for difficult endotracheal intubation utilizing both direct and indirect laryngoscopy techniques, and a major reason for anesthesia-related adverse events. Over the past two decades, videolaryngoscopy has evolved to be the primary indirect laryngoscopy technique in a difficult endotracheal intubation setting. The possibility for optimal visualization of the laryngeal structures renders this method particularly helpful in patients with limited mouth opening. Especially videolaryngoscopy with acute-angle blades has been proposed to be favorable over conventional direct laryngoscopy in this setting. However, previous research has shown that a mouth opening of approximately 2.0 - 3.0 cm represents an independent risk factor and a possible critical lower limit for safe videolaryngoscopic intubation.

The latest generation of GlideScopeTM Spectrum blades may provide sufficient intubation conditions even in patients with a maximum mouth opening below 3.0 cm.

Our research group aims to evaluate the clinical performance, quality of larynx visualization and severity of videolaryngoscopic intubation the GlideScopeTM Spectrum system in patients with a small mouth opening.

Keywords
GlideScope, Airway Management, Videolaryngoscopic Intubation
Medical subject headings
Microstomia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Successful videolaryngoscopic endotracheal intubation rate

    Observation during airway management

    Measured: Within 1 hour after anesthesia induction

Secondary outcomes (5)
  1. First pass success rate

    Observation during airway management

    Measured: Within 1 hour after anesthesia induction

  2. Endotracheal intubation difficulty

    Subjective rating on a numeric rating scale [0-100]; 0 - very easy; 100 - very difficult

    Measured: Within 1 hour after concluded endotracheal intubation

  3. Best view obtained

    Cormack-Lehane classification

    Measured: Within 1 hour after concluded endotracheal intubation

  4. Intubation time

    Observation during airway management

    Measured: Within 1 hour after anesthesia induction

  5. Number of attempts

    Observation during airway management

    Measured: Within 1 hour after anesthesia induction

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2019
  2. Study start20 Jan 2021
  3. Primary completion17 Nov 2021
  4. Study completion17 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04174833
Sponsor's protocol ID
PV6094
Status last verified
Nov 2021
First submitted
6 Oct 2019
Last updated
24 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intubation;Difficult and Videolaryngoscopy, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Successful videolaryngoscopic endotracheal intubation rate (time frame: Within 1 hour after anesthesia induction). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in